Nature's Only Choice Recall: The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug. - F-1480-2018
United States
TerminatedClass II
- Company
- Nature's Only Choice
- Product
- Nature's Only Choice B17 BITTER RAW APRICOT EXTRACT AMYGDALI…
- Recall date
- May 16, 2018
- Terminated
- June 29, 2018
- Source
- FDA
Reason for recall
The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug.
- - Recall initiated
- - Reported by source
- - Recall terminated
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Nature's Only Choice B17 BITTER RAW APRICOT EXTRACT AMYGDALIN Dietary Supplement 100 Capsules | Not published in this source record | 250 bottles | Expiration Date: 06/2019 |
Distribution
- Nationwide and worldwide.
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- F-1480-2018
- Event ID
- 80073
- Status
- Terminated
- Classification
- Class II
- Company
- Nature's Only Choice
- Product description
- Nature's Only Choice B17 BITTER RAW APRICOT EXTRACT AMYGDALIN Dietary Supplement 100 Capsules
- Quantity
- 250 bottles
- Reason
- The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug.
- Recall initiation date
- May 16, 2018
- Report date
- May 30, 2018
- Classification date
- Not published in this source record
- Termination date
- June 29, 2018
- Distribution pattern
- Nationwide and worldwide.
- UPC, lot, and code information
- Expiration Date: 06/2019
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Responsible company: Nature's Only Choice
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.
New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class II mean?
FDA classifies this recall as Class II. See how to read an FDA recall record (linked above) for what each classification level means.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.
Official guidance and record verification
Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.
How to interpret this historical record
This record is preserved as published by FDA, as of June 29, 2018.
Status as reported: Terminated.
This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.